CRIS Current Research Information System

RIZZELLO, FERNANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.403
AS - Asia 10.297
EU - Europa 7.687
AF - Africa 784
SA - Sud America 667
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 9
Totale 30.867
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.211
SG - Singapore 2.772
VN - Vietnam 2.732
CN - Cina 2.568
IT - Italia 1.682
GB - Regno Unito 1.616
DE - Germania 938
SE - Svezia 780
HK - Hong Kong 730
FR - Francia 556
BR - Brasile 482
IN - India 466
RU - Federazione Russa 409
UA - Ucraina 348
IE - Irlanda 300
NL - Olanda 223
KR - Corea 214
FI - Finlandia 203
ZA - Sudafrica 194
CI - Costa d'Avorio 183
JP - Giappone 180
SC - Seychelles 158
TG - Togo 153
CH - Svizzera 114
BG - Bulgaria 109
JO - Giordania 108
EE - Estonia 107
AR - Argentina 90
PH - Filippine 82
CA - Canada 69
BE - Belgio 67
IQ - Iraq 50
ID - Indonesia 49
PL - Polonia 49
ES - Italia 47
BD - Bangladesh 46
MX - Messico 44
TH - Thailandia 41
TR - Turchia 40
HN - Honduras 37
TW - Taiwan 37
AT - Austria 36
PK - Pakistan 27
SA - Arabia Saudita 27
UZ - Uzbekistan 27
GR - Grecia 26
NG - Nigeria 24
EC - Ecuador 20
CL - Cile 19
IR - Iran 19
AU - Australia 17
BZ - Belize 17
CO - Colombia 15
EG - Egitto 15
PY - Paraguay 15
LT - Lituania 14
CZ - Repubblica Ceca 13
RO - Romania 13
ET - Etiopia 12
VE - Venezuela 12
LB - Libano 10
MA - Marocco 10
MY - Malesia 10
TN - Tunisia 9
HR - Croazia 8
KE - Kenya 8
IL - Israele 7
KZ - Kazakistan 7
NP - Nepal 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AZ - Azerbaigian 6
BO - Bolivia 5
DZ - Algeria 5
EU - Europa 5
JM - Giamaica 5
PE - Perù 5
PS - Palestinian Territory 5
AL - Albania 4
DO - Repubblica Dominicana 4
SK - Slovacchia (Repubblica Slovacca) 4
SY - Repubblica araba siriana 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
MN - Mongolia 3
RS - Serbia 3
BW - Botswana 2
CR - Costa Rica 2
DK - Danimarca 2
GD - Grenada 2
GE - Georgia 2
HU - Ungheria 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MD - Moldavia 2
MU - Mauritius 2
NO - Norvegia 2
OM - Oman 2
QA - Qatar 2
Totale 30.836
Salva come PNG Salva come JPEG
Città #
Singapore 1.888
Southend 1.340
Ashburn 1.314
Fairfield 1.047
Chandler 829
Hong Kong 687
Ho Chi Minh City 600
Woodbridge 524
Santa Clara 513
San Jose 511
Hanoi 487
Houston 485
Hefei 481
Wilmington 454
Seattle 429
Princeton 382
Beijing 367
Cambridge 343
Bologna 332
Dong Ket 326
Ann Arbor 323
Dublin 299
Boardman 240
Lauterbourg 216
Abidjan 183
Seoul 178
Jacksonville 176
Helsinki 169
Nanjing 169
Lomé 153
Tokyo 153
New York 150
Westminster 147
Los Angeles 143
Milan 123
Berlin 122
Padova 122
Sofia 108
Amman 107
San Diego 99
Buffalo 98
Frankfurt am Main 98
Bern 92
Dallas 88
Da Nang 85
Haiphong 84
Council Bluffs 79
Shenyang 75
Turin 74
Redondo Beach 71
Rome 70
Jinan 68
Saint Petersburg 66
Guangzhou 65
Johannesburg 64
Changsha 57
Munich 57
Phoenix 54
São Paulo 53
Bengaluru 52
Hebei 50
Brussels 48
Shanghai 48
Redwood City 44
Mülheim 43
Orem 42
Medford 41
Redmond 39
Nanchang 38
Des Moines 36
Bremen 35
London 34
Tianjin 34
Yubileyny 34
Dearborn 33
Florence 33
Henderson 33
Nuremberg 33
Chicago 29
Atlanta 28
Falkenstein 28
Zhengzhou 28
Hangzhou 27
Saint Louis 27
Centro 26
Falls Church 26
Hải Dương 26
Jiaxing 26
Can Tho 25
Biên Hòa 24
Mahé 24
Montreal 24
Norwalk 23
Thái Nguyên 23
Washington 23
Amsterdam 22
Modena 22
Warsaw 22
Brierley Hill 21
Brooklyn 21
Totale 19.412
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 656
Ulcerative Colitis 356
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 317
Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis 310
COVID-19 in IBD: The experience of a single tertiary IBD center 299
Adult attachment and early parental experiences in patients with Crohn’s Disease 250
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 243
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 240
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 238
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 238
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 235
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 229
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 226
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 221
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 220
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 216
Adalimumab in active ulcerative colitis: a "real-life" observational study. 215
Medical treatment and management of severe ulcerative colitis 215
Infliximab in the treatment of Crohn's disease 212
Cyclooxygenase-2 Silencing for the Treatment of Colitis: A Combined In Vivo Strategy Based on RNA Interference and Engineered Escherichia Coli 212
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 212
Attachment and quality of life in patients with inflammatory bowel disease 210
High-dose probiotics for the treatment of active pouchitis 204
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 202
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 199
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 197
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 197
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 196
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 196
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 195
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 195
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 194
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study 194
Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically 192
Clinical course of microscopic colitis in a single-center cohort study 192
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 192
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 191
Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn's Disease 190
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 190
Implications of antioxidant enzymes in human gastric neoplasms 189
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 187
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 187
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 187
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 186
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 186
Antibiotics and probiotics in treatment of inflammatory bowel disease 186
Management and treatment of distal ulcerative colitis 185
Implications of the westernized diet in the onset and progression of IBD 184
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 181
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 181
Oral budesonide in the treatment of chronic refractory pouchitis. 180
Platelet lysate enhances the therapeutic activity of Adipose Derived Mesenchymal stromal cells isolated from Crohn disease patients in a novel Mouse model of Colitis 180
Role of conventional therapies in the era of biological treatment in Crohn's disease. 179
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 178
Review article: aminosalicylates for distal colitis 177
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 177
Parental Bonding and Inflammatory Bowel Disease 177
Management of inflammatory bowel disease: does rifaximin offer any promises 176
Probiotics in IBD: A critical review 176
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 175
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 175
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages 174
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 174
Role of Biologics in refractory pouchitis 174
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 173
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 171
The role of Budesonide-MMX in active ulcerative colitis. 171
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 170
Percutaneous abdomino-pelvic abscess drainage in complicated Crohn’s disease 169
Antimicrobials in the management of inflammatory bowel disease 168
MANAGEMENT OF POUCHITIS 168
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 167
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 167
Which therapies are advisable in pouchitis? 165
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 165
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 164
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 163
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 162
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 162
Oral Budesonide and low serum albumin levels at surgery are associated with a higher risk of postoperative intra-abdominal septic complications after primary ileocaecal resection for Crohn's disease: A retrospective analysis of 853 consecutive patients 161
Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis? 161
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 161
Problematic proctitis and distal colitis 161
Pre-pouch ileitis 160
Sympathetic hyperactivity in patients with ulcerative colitis. 160
Randomized controlled trials in pouchitis 160
Oral beclomethasone dipropionate in chronic refractory pouchitis 159
A current overview of corticosteroid use in active ulcerative colitis 158
Safety and Efficacy of Vedolizumab in Kidney Transplant Recipients With Crohn’s Disease 158
Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 157
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 156
DOP62 Morbidity after primary ileocecal resection for Crohn’s disease in the years of biologics: Lesson learned over 631 patients exclusively treated in a tertiary centre 156
Budesonide MMX: efficacy and safety profile in the treatment of ulcerative colitis 156
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 155
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 155
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 153
Probiotics, Prebiotics, and Antibiotics in IBD 153
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 152
Rescue therapy: ciclosporin or infliximab? 151
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 149
Totale 19.394
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.046 0 0 0 0 0 0 0 0 0 220 96 730
2021/20223.297 350 93 216 159 293 168 82 192 202 235 812 495
2022/20233.776 393 508 182 459 246 313 102 209 736 104 268 256
2023/20241.218 80 198 109 92 95 290 73 76 35 65 46 59
2024/20254.579 247 685 387 291 719 223 283 160 108 339 215 922
2025/202610.373 1.021 1.123 963 830 1.237 700 1.140 370 2.224 765 0 0
Totale 31.642